![]() |
|
|
IIb
3 in Human Embryonic Kidney
293 Cells
Departments of
Pharmacology (D.G.A., R.A.B., B.B., R.J.G.) and
Bone
Biology and Osteoporosis (E.M.N., L.T.D.), Merck Research Laboratories,
West Point, Pennsylvania 19486
The platelet-specific integrin
IIb
3 achieves a high affinity
binding state in response to extracellular agonists such as thrombin,
ADP, or collagen. During this activation, the receptor undergoes a
number of conformational changes. To characterize the different
conformations of
IIb
3, we expressed recombinant
IIb
3 in
human embryonic kidney (HEK) 293 cells. Antigenic and peptide
recognition specificities of the full-length recombinant receptor
resembled those of the native receptor in platelets. We used an array
of peptidic and nonpeptidic arginine-glycine-aspartic acid (RGD) mimics
that specifically bind to human platelet
IIb
3 to determine the
affinity state of the receptor. Some of these RGD mimics were
previously shown to clearly discriminate between resting and activated
IIb
3. Solution-phase binding of these RGD mimics to the
recombinant cells suggested that in HEK 293 cells the full-length
IIb
3 is expressed in a "transitional" activation state. This
observation was confirmed by the binding of the activation-specific,
monoclonal anti-
IIb
3 antibody PAC1 to cells expressing the
full-length recombinant
IIb
3. Deletion of the entire cytoplasmic
domain of the
subunit was sufficient to convert the receptor in HEK
293 cells to a fully active form, as found in activated platelets. In
addition, the full-length receptor was capable of mediating
agonist-independent aggregation of cells in the presence of fibrinogen.
Thus, by using RGD mimics, we have identified a functional transitional
activation state of
IIb
3 that is capable of mediating
fibrinogen-dependent cell aggregation.
This article has been cited by other articles:
![]() |
C. C. Quattrocchi, F. Wannenes, A. M. Persico, S. A. Ciafre, G. D'Arcangelo, M. G. Farace, and F. Keller Reelin Is a Serine Protease of the Extracellular Matrix J. Biol. Chem., January 4, 2002; 277(1): 303 - 309. [Abstract] [Full Text] |
||||
![]() |
B. Bednar, J. J. Cook, M. A. Holahan, M. E. Cunningham, P. A. Jumes, R. A. Bednar, G. D. Hartman, and R. J. Gould Fibrinogen Receptor Antagonist-Induced Thrombocytopenia in Chimpanzee and Rhesus Monkey Associated With Preexisting Drug-Dependent Antibodies to Platelet Glycoprotein IIb/IIIa Blood, July 15, 1999; 94(2): 587 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. O. Simon, E. M. Nutt, D. G. Abraham, G. A. Rodan, and L. T. Duong The alpha vbeta 3 Integrin Regulates alpha 5beta 1-mediated Cell Migration toward Fibronectin J. Biol. Chem., November 14, 1997; 272(46): 29380 - 29389. [Abstract] [Full Text] [PDF] |
||||